A systematic review on the improvement of skin moisture retention by the functional participating component "glucosylceramide" - A systematic review on the improvement of skin moisture retention by the functional participating component "glucosylceramide"
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Clinical research paper carried out on healthy subjects not suffering from skin diseases
- Sponsor
- Adaptgen Pharmaceutical Co., Ltd.
- Enrollment
- 1
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Relationship between the results of research review and the functionality to be displayed As a result of the SR study, the outcome with respect to the RQ / QC set for the functionality (effectiveness) given to a person by the functional participating component glucosylceramide is to consume glucosylceramide continuously from 0.6 mg to 4.0 mg per day By improving the barrier function of the skin and water retention ability and improving the moisturizing function "as confirmed by this SR research, the ancestor and divergence between the display contents and the literature It can be denied. Also regarding safety, there were no adverse events that glucosylceramide is considered to be a direct cause, and certain safety was also confirmed.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •\[Exclusion Criteria] In the secondary screening, provisional candidate documents are obtained by the abstract, and those corresponding to one or more of the following exclusion criteria are excluded from the candidate literature. 1\. Clinical research literature for subjects suffering from skin diseases 2\. Literature of clinical research for minors 3\. Clinical research literature for pregnant women and lactating women 4\. Clinical research literature not reviewed 5\. Literature of clinical study without comparative control group 6\. Literature of clinical study in which the main involved component is not glucosylceramide 7\. Clinical research literature which can not be evaluated by glucosylceramide and other equivalent ingredients 8\. In addition, clinical research literature judged inappropriate by the reviewer's agreement
Outcomes
Primary Outcomes
Not specified